SCHEMBL25634037

SCHEMBL25634037

Oc1ccc2ccccc2c1-c1c2ccccc2c(-c2ccc3ccccc3c2)c2cc(-c3ccc4c(-c5c(O)ccc6ccccc56)c5ccccc5c(-c5ccc6ccccc6c5)c4c3)ccc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.53
▸ HSD17B1 P14061 9/20 0.51
▸ HSD17B2 P37059 9/20 0.51
▸ CYP1A2 P05177 4/20 0.51
▸ CYP3A4 P08684 4/20 0.51
▸ CYP2D6 P10635 4/20 0.51
▸ CYP2C9 P11712 4/20 0.51
▸ CYP2B6 P20813 4/20 0.51
▸ CYP2C19 P33261 4/20 0.51
▸ ESR1 P03372 2/20 0.50
▸ ESR2 Q92731 2/20 0.50
▸ ACMSD Q8TDX5 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PTPN22 Q9Y2R2 1/20 0.41
▸ HDAC4 P56524 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25060829 0.94 ALOX5 (0.59) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL30874112 0.85 ALOX5 (0.66) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL22795574 0.85 ALOX5 (0.60) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL18736016 0.85 ALOX5 (0.66) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL269358 0.85 ESR1 (0.50) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL2964464 0.85 ESR1 (0.50) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL18880023 0.84 CYP1B1 (0.48) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL14506092 0.83 ESR2 (0.59) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL21238074 0.82 ESR1 (0.52) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4
SCHEMBL19720301 0.82 ESR1 (0.52) ALOX5HSD17B1HSD17B2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180596-A1 Novel Compound and Organic Light Emitting Device Comprising the Same LG CHEM, LTD. (KR) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180596-A1 Novel Compound and Organic Light Emitting Device Comprising the Same CRY1, CRY2, CYBA ALOX5 774/4885HSD17B1 810/4885HSD17B2 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback